SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001828
Filing Date
2019-06-07
Accepted
2019-06-07 12:01:32
Documents
42
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q odyssey_10q-043019.htm 10-Q 237705
2 CERTIFICATION odyssey_10q-ex3101.htm EX-31.1 7342
3 CERTIFICATION odyssey_10q-ex3102.htm EX-31.2 7388
4 CERTIFICATION odyssey_10q-ex3200.htm EX-32 3496
  Complete submission text file 0001683168-19-001828.txt   1059852

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE odyy-20190430.xml EX-101.INS 76643
6 XBRL SCHEMA FILE odyy-20190430.xsd EX-101.SCH 15811
7 XBRL CALCULATION FILE odyy-20190430_cal.xml EX-101.CAL 25693
8 XBRL DEFINITION FILE odyy-20190430_def.xml EX-101.DEF 37722
9 XBRL LABEL FILE odyy-20190430_lab.xml EX-101.LAB 101444
10 XBRL PRESENTATION FILE odyy-20190430_pre.xml EX-101.PRE 87238
Mailing Address 2372 MORSE AVE. IRVINE CA 92614
Business Address 2372 MORSE AVE. IRVINE CA 92614 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

IRS No.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-200785 | Film No.: 19884766
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1